abstract |
The present invention relates to N-oxide and / or di-N-oxide derivatives of dopamine receptor stabilizers / regulators having the general formula (1) or (2), and pharmaceutical formulations containing said compounds. Furthermore, the present invention relates to the use of said compounds for the treatment of disorders in the central nervous system and in particular for the treatment of dopamine-mediated disorders such as eg movement disorders, psychosis, anxiety disorders, neurodevelopment disorders, sleep disorders and chemical-related disorders. Regarding use. |